These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 28589341)
21. Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods. Martínez-Carretero C; Pascual FI; Rus A; Bernardo I Clin Chem Lab Med; 2017 Oct; 55(12):1970-1978. PubMed ID: 28432840 [TBL] [Abstract][Full Text] [Related]
22. EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study. Malapelle U; de Luca C; Vigliar E; Ambrosio F; Rocco D; Pisapia P; Bellevicine C; Troncone G J Clin Pathol; 2016 May; 69(5):454-7. PubMed ID: 26893402 [TBL] [Abstract][Full Text] [Related]
23. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698 [TBL] [Abstract][Full Text] [Related]
24. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer. O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958 [TBL] [Abstract][Full Text] [Related]
25. EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer. Zheng HY; Wang HB; Shen FJ; Tong YQ; Yao Q; Qiao B; Sun S; Li Y Curr Med Sci; 2020 Feb; 40(1):78-84. PubMed ID: 32166668 [TBL] [Abstract][Full Text] [Related]
26. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. Pan Q; Pao W; Ladanyi M J Mol Diagn; 2005 Aug; 7(3):396-403. PubMed ID: 16049312 [TBL] [Abstract][Full Text] [Related]
27. Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR. Wang L; Guo Q; Yu W; Qiao L; Zhao M; Zhang C; Hu X; Yang G; Xiong L; Lou J Lung Cancer; 2017 Dec; 114():31-37. PubMed ID: 29173762 [TBL] [Abstract][Full Text] [Related]
28. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085 [TBL] [Abstract][Full Text] [Related]
29. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry. Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121 [TBL] [Abstract][Full Text] [Related]
30. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients. Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment. Zhu L; Zhang S; Xun Y; Jiang Y; Xia B; Chen X; Wang L; Jiang H; Ma S Pathol Oncol Res; 2018 Oct; 24(4):843-851. PubMed ID: 28868565 [TBL] [Abstract][Full Text] [Related]
32. Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients. Pasquale R; Fenizia F; Esposito Abate R; Sacco A; Esposito C; Forgione L; Rachiglio AM; Bevilacqua S; Montanino A; Franco R; Rocco G; Botti G; Denis MG; Morabito A; De Luca A; Normanno N Pharmacogenomics; 2015; 16(10):1135-48. PubMed ID: 26249748 [TBL] [Abstract][Full Text] [Related]
33. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer. Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213 [TBL] [Abstract][Full Text] [Related]
34. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens. Xu H; Sun W; Zhang G; Cheng Y J BUON; 2015; 20(1):142-5. PubMed ID: 25778309 [TBL] [Abstract][Full Text] [Related]
35. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice. Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127 [TBL] [Abstract][Full Text] [Related]
36. Allele-specific PCR method for identification of EGFR mutations in non-small cell lung cancer: formalin-fixed paraffin-embedded tissue versus fresh tissue. Suciu BA; Pap Z; Dénes L; Brînzaniuc K; Copotoiu C; Pávai Z Rom J Morphol Embryol; 2016; 57(2):495-500. PubMed ID: 27516024 [TBL] [Abstract][Full Text] [Related]
37. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing]. Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296 [TBL] [Abstract][Full Text] [Related]
38. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Yu J; Kane S; Wu J; Benedettini E; Li D; Reeves C; Innocenti G; Wetzel R; Crosby K; Becker A; Ferrante M; Cheung WC; Hong X; Chirieac LR; Sholl LM; Haack H; Smith BL; Polakiewicz RD; Tan Y; Gu TL; Loda M; Zhou X; Comb MJ Clin Cancer Res; 2009 May; 15(9):3023-8. PubMed ID: 19366827 [TBL] [Abstract][Full Text] [Related]
39. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085 [TBL] [Abstract][Full Text] [Related]
40. [Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer]. Wang S; Han XH; Li JL; Hu XS; Wang XY; Gui L; Zhao LD; Sun Y; Shi YK Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):530-3. PubMed ID: 23157744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]